Know Cancer

or
forgot password

Genome-wide Pharmacogenetic Candidate Gene SNP Array-based Approach to Predict Chemoresponse and Survival in Patients With Acute Myeloid Leukemia With Normal Karyotype


N/A
18 Years
N/A
Open (Enrolling)
Both
Myeloid Leukemia

Thank you

Trial Information

Genome-wide Pharmacogenetic Candidate Gene SNP Array-based Approach to Predict Chemoresponse and Survival in Patients With Acute Myeloid Leukemia With Normal Karyotype


Inclusion Criteria:



- patients with normal karyotype acute myeloid leukemia

- 18 years or older

- patients were treated with standard chemotherapy

- patients with available medical record and stored bone marrow specimen at time of
diagnosis

Exclusion Criteria:

- no definitive criteria

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Retrospective

Outcome Measure:

overall response rate

Outcome Time Frame:

within 1 month after enrollment

Safety Issue:

No

Principal Investigator

Dong Hwan Kim, M.D.,Ph.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Division of Hematology and Oncology/Samsung Medical Center

Authority:

South Korea: Institutional Review Board

Study ID:

2009-10-070

NCT ID:

NCT01066338

Start Date:

February 2010

Completion Date:

Related Keywords:

  • Myeloid Leukemia
  • SNP array
  • prognosis
  • acute myeloid leukemia
  • normal karyotype
  • acute myeloid leukemia with normal karyotype
  • Leukemia
  • Leukemia, Myeloid, Acute
  • Leukemia, Myeloid

Name

Location